2017 Annual Meeting | N3 - Neuroscience in the Clinic: Cutting Edge Concussion Data from the NCAA-DoD Grand Alliance
| 01:00 PM - 01:05 PM | Luncheon |
Introduction
Brian W. Hainline, MD, FAAN |
| 01:00 PM - 03:00 PM | Abstract |
001 - Migraine History and Associated Comorbidities in High School Athletes
Magdalena Wojtowicz, PhD |
| 01:00 PM - 03:00 PM | Abstract |
002 - Between Trial Reliability of the King Devick Test
Katherine Breedlove, PhD |
| 01:05 PM - 01:15 PM | Speaker |
Concussion as a Public Health Matter: Setting the Stage
Brian W. Hainline, MD, FAAN |
| 01:15 PM - 01:35 PM | Speaker |
Concussion Pathophysiology: What We Know and What We Need to Know
Christopher Giza, MD, FAAN |
| 01:35 PM - 02:00 PM | Speaker |
CARE Consortium: Emerging Results and Implications for Concussion Management and Policy
Michael McCrea, PhD, ABPP |
| 02:00 PM - 02:15 PM | Speaker |
N3.001: Migraine History and Associated Comorbidities in High School Athletes
Magdalena Wojtowicz, PhD |
| 02:15 PM - 02:30 PM | Speaker |
N3.002: Between Trial Reliability of the King Devick Test
Katherine Breedlove, PhD |
| 02:30 PM - 03:00 PM | Q&A |
Panel Discussion
|
| Christopher Giza, MD, FAAN | Dr. Giza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical Network Speakers Bureau. Dr. Giza has stock in Highmark Interactive. The institution of Dr. Giza has received research support from UCLA: Brain Injury Research Center, Steve Tisch BrainSPORT Program, Easton Clinic for Brain Health. Dr. Giza has received publishing royalties from a publication relating to health care. Dr. Giza has a non-compensated relationship as a Advisory Board with Major League Soccer that is relevant to AAN interests or activities. Dr. Giza has a non-compensated relationship as a Advisory Board with National Basketball Association that is relevant to AAN interests or activities. Dr. Giza has a non-compensated relationship as a Consultant with United States Soccer Federation that is relevant to AAN interests or activities. Dr. Giza has a non-compensated relationship as a Co-founder & Advisor with Symptomwise that is relevant to AAN interests or activities. |
| Brian W. Hainline, MD, FAAN | Dr. Hainline has received intellectual property interests from a publication relating to health care. |
| Michael McCrea, PhD, ABPP | Dr. McCrea has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurotrauma Sciences. The institution of Dr. McCrea has received research support from NIH. The institution of Dr. McCrea has received research support from DoD. The institution of Dr. McCrea has received research support from NCAA. The institution of Dr. McCrea has received research support from NFL. The institution of Dr. McCrea has received research support from CDC. The institution of Dr. McCrea has received research support from Abbott Labs. Dr. McCrea has received publishing royalties from a publication relating to health care. |
| Magdalena Wojtowicz, PhD | No disclosure on file |
| Katherine Breedlove, PhD | No disclosure on file |
| No disclosure on file | |
| James Clugston, MD, MS, CAQSM | No disclosure on file |
| Tad D. Seifert, MD | Dr. Seifert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly Pharmaceuticals. Dr. Seifert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen Pharmaceuticals. Dr. Seifert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck Pharmaceuticals . Dr. Seifert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus Pharmaceuticals . Dr. Seifert has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly Pharmaceuticals . Dr. Seifert has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Pharmaceuticals . |
| Jessie Oldham | No disclosure on file |
| Thomas A. Buckley, PhD | The institution of Dr. Buckley has received research support from Henry M. Jackson Foundation for the Advancement of Military Medicine. The institution of Dr. Buckley has received research support from NIH/NINDS. Dr. Buckley has received research support from Nevada COBRE. The institution of Dr. Buckley has received research support from NCAA. |
| Sara Chrisman | No disclosure on file |
| Melissa S. DiFabio | No disclosure on file |
| Grant Iverson, PhD | Grant Iverson, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sway Medical. Grant Iverson, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NanoDX. The institution of Grant Iverson, PhD has received research support from Wounded Warrior Project. Grant Iverson, PhD has received publishing royalties from a publication relating to health care. Grant Iverson, PhD has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with NeuroHealth, LLC. |
| Ross Zafonte, DO | Dr. Zafonte has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MYOMO. Dr. Zafonte has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kisbee. Dr. Zafonte has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology. The institution of Dr. Zafonte has received research support from NIDILRR. The institution of Dr. Zafonte has received research support from NIH. The institution of Dr. Zafonte has received research support from FPHS study. Dr. Zafonte has received publishing royalties from a publication relating to health care. |
| Anthony Kontos | No disclosure on file |